Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Depreciation & Amortization (CF): 2009-2024

Historic Depreciation & Amortization (CF) for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Dec 2024 value amounting to $4.9 million.

  • Cumberland Pharmaceuticals' Depreciation & Amortization (CF) fell 7.01% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.6 million, marking a year-over-year decrease of 0.86%. This contributed to the annual value of $4.9 million for FY2024, which is 0.68% down from last year.
  • Latest data reveals that Cumberland Pharmaceuticals reported Depreciation & Amortization (CF) of $4.9 million as of FY2024, which was down 0.68% from $4.9 million recorded in FY2023.
  • Cumberland Pharmaceuticals' Depreciation & Amortization (CF)'s 5-year high stood at $5.3 million during FY2022, with a 5-year trough of $4.6 million in FY2021.
  • Its 3-year average for Depreciation & Amortization (CF) is $5.1 million, with a median of $4.9 million in 2023.
  • Per our database at Business Quant, Cumberland Pharmaceuticals' Depreciation & Amortization (CF) rose by 15.67% in 2022 and then decreased by 7.36% in 2023.
  • Yearly analysis of 5 years shows Cumberland Pharmaceuticals' Depreciation & Amortization (CF) stood at $4.7 million in 2020, then declined by 2.99% to $4.6 million in 2021, then grew by 15.67% to $5.3 million in 2022, then declined by 7.36% to $4.9 million in 2023, then dropped by 0.68% to $4.9 million in 2024.